Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Myomo, Inc.

< Previous 1 2 3 Next >
Myomo to Report Fourth Quarter Financial Results on March 7, 2024
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations
From Myomo, Inc.
Via Business Wire
Tickers MYO
CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Report Third Quarter Financial Results on November 7, 2023
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces Closing of $4.4 Million Public Offering
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces Pricing of $4.4 Million Public Offering
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo, Inc. Announces Proposed Public Offering
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Report Second Quarter Financial Results on August 9, 2023
From Myomo, Inc.
Via Business Wire
Tickers MYO
Centers for Medicare and Medicaid Services Accepts Myomo’s Application to Classify the MyoPro® as a Brace
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Report First Quarter Financial Results on May 10, 2023
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Receives Technology License Fee Payment from China Joint Venture Company
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Makes NYSE American Section 610(b) Public Announcement
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Reports Fourth Quarter and Full Year 2022 Financial Results
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo to Report Fourth Quarter Financial Results on March 13, 2023
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo To Participate in the 35th Annual Roth Conference
From Myomo, Inc.
Via Business Wire
Tickers MYO
MyoPro Approved in Australia by National Disability Insurance Scheme
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Appoints Yitzchak Jacobovitz to its Board of Directors
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces Closing of $6.5 Million Upsized Public Offering
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces Pricing of $6.5 Million Upsized Public Offering
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Announces Initiative to Reduce Cash Burn
From Myomo, Inc.
Via Business Wire
Tickers MYO
Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro
From Myomo, Inc.
Via Business Wire
Tickers MYO
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.